blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2826471

EP2826471 - Use of hif alpha stabilizers for enhancing erythropoiesis [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  12.07.2024
Database last updated on 09.04.2026
FormerGrant of patent is intended
Status updated on  12.11.2023
FormerExamination is in progress
Status updated on  07.09.2018
Most recent event   Tooltip12.07.2024Application deemed to be withdrawnpublished on 14.08.2024  [2024/33]
Applicant(s)For all designated states
Fibrogen, Inc.
409 Illinois Street
San Francisco, CA 94158 / US
[2015/04]
Inventor(s)01 / Klaus, Stephen J.
1255 California Street, 702
San Francisco, CA California 94109 / US
02 / Molineaux, Christopher J.
2475 Butternut Drive
Hillsborough, CA California 94016 / US
03 / Neff, Thomas B.
190 Glenwood Avenue
Atherton, CA California 94027 / US
04 / Guenzler-Pukall, Volkmar
1041 Aileen Street
Emeryville, CA California 94608 / US
05 / Lansetmo Parobok, Ingrid
1524 Sonoma Drive
Milpitas, CA California 95035 / US
06 / Seeley, Todd W.
5 Harold Drive
Moraga, CA California 94556 / US
07 / Stephenson, Robert C.
2339 39th Avenue
San Francisco, CA California 94116 / US
 [2015/04]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2015/04]
Application number, filing date14178232.604.06.2004
[2015/04]
Priority number, dateUS20030476704P06.06.2003         Original published format: US 476704 P
US20040566488P29.04.2004         Original published format: US 566488 P
US20040566237P29.04.2004         Original published format: US 566237 P
US20040569797P10.05.2004         Original published format: US 569797 P
US2004086159003.06.2004         Original published format: US 861590
[2015/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2826471
Date:21.01.2015
Language:EN
[2015/04]
Search report(s)(Supplementary) European search report - dispatched on:EP22.12.2014
ClassificationIPC:A61K31/00, A61K31/395, A61K31/165, A61P7/06
[2015/04]
CPC:
C07D217/24 (EP,KR,NO,US); A61K31/00 (EP,NO,US); A61K31/165 (EP,KR,NO,US);
A61K31/17 (EP,KR,US); A61K31/395 (EP,KR,NO,US); A61K31/472 (EP,KR,US);
A61P1/00 (EP); A61P19/02 (EP); A61P29/00 (EP);
A61P3/02 (EP); A61P31/00 (EP); A61P35/00 (EP);
A61P37/00 (EP); A61P37/02 (EP); A61P43/00 (EP);
A61P7/00 (EP); A61P7/06 (EP,KR); C07C275/40 (KR,NO,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/35]
Former [2015/04]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IT,  LI,  LU,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL21.07.2015
HR21.07.2015
LT21.07.2015
LV21.07.2015
MK21.07.2015
TitleGerman:Verwendung von HIF-Alpha-Stabilisatoren zur Verbesserung der Erythropoese[2015/04]
English:Use of hif alpha stabilizers for enhancing erythropoiesis[2015/04]
French:Utilisation de stabilisateurs de HIF Alpha pour améliorer l'érythropoïèse[2015/04]
Examination procedure21.07.2015Amendment by applicant (claims and/or description)
21.07.2015Examination requested  [2015/35]
06.09.2018Despatch of a communication from the examining division (Time limit: M06)
14.06.2019Reply to a communication from the examining division
04.12.2020Despatch of a communication from the examining division (Time limit: M06)
16.09.2021Reply to a communication from the examining division
13.11.2023Communication of intention to grant the patent
14.03.2024Application deemed to be withdrawn, date of legal effect  [2024/33]
05.04.2024Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2024/33]
Parent application(s)   TooltipEP04754383.0  / EP1633333
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
16.09.2021Request for further processing filed
16.09.2021Full payment received (date of receipt of payment)
Request granted
27.09.2021Decision despatched
The application is deemed to be withdrawn due to failure to reply to the examination report
14.06.2019Request for further processing filed
14.06.2019Full payment received (date of receipt of payment)
Request granted
28.06.2019Decision despatched
Fees paidRenewal fee
23.07.2014Renewal fee patent year 03
23.07.2014Renewal fee patent year 04
23.07.2014Renewal fee patent year 05
23.07.2014Renewal fee patent year 06
23.07.2014Renewal fee patent year 07
23.07.2014Renewal fee patent year 08
23.07.2014Renewal fee patent year 09
23.07.2014Renewal fee patent year 10
23.07.2014Renewal fee patent year 11
10.06.2015Renewal fee patent year 12
10.06.2016Renewal fee patent year 13
16.06.2017Renewal fee patent year 14
12.06.2018Renewal fee patent year 15
13.06.2019Renewal fee patent year 16
15.06.2020Renewal fee patent year 17
14.06.2021Renewal fee patent year 18
26.05.2022Renewal fee patent year 19
20.06.2023Renewal fee patent year 20
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XDP] WO03049686  (FIBROGEN INC et al.)
 [XP] WO03053997  (FIBROGEN INC et al.)
 [XP] WO03057820  (KIMBERLY CLARK CO et al.)
 [X] WO0074725  (DANA FARBER CANCER INST INC et al.)
 [X]   AUCELLA, FILIPPO ET AL: "Synergistic effect of desferrioxamine and recombinant erythropoietin on erythroid precursor proliferation in chronic renal failure", NEPHROLOGY, DIALYSIS, TRANSPLANTATION , 14(5), 1171-1175 CODEN: NDTREA; ISSN: 0931-0509, 1999, XP002300229

DOI:   http://dx.doi.org/10.1093/ndt/14.5.1171
 [X]   SALVARANI C ET AL: "Effects of desferrioxamine therapy on chronic disease anemia associated with rheumatoid arthritis", RHEUMATOLOGY INTERNATIONAL, vol. 16, no. 2, 1996, pages 45 - 48, XP009037762, ISSN: 0172-8172

DOI:   http://dx.doi.org/10.1007/BF01816434
by applicantWO03053977
 WO03049686
 US6562799
 US6124131
 US6432927
 WO03045440
 WO03053997
 EP0650960
 EP0650961
 US5658933
 US5620995
 US6020350
 US5607954
 US5610172
 US5620996
 US5719164
 US5726305
 US6093730
 WO0050390
 WO0069908
 US5942434
   MEANS, STEM CELLS, vol. 13, 1995, pages 32 - 37
   MEANS, INT J HEMATOL, vol. 70, 1999, pages 7 - 12
   ROODMAN ET AL., ADV EXP MED BIOL, vol. 271, 1989, pages 185 - 196
   FUCHS ET AL., EUR J HEMATOL, vol. 46, 1991, pages 65 - 70
   JELKMANN ET AL., ANN NY ACAD SCI, vol. 718, 1994, pages 300 - 311
   VANNUCCHI ET AL., BR J HEMATOL, vol. 87, 1994, pages 18 - 23
   OLDENBURG ET AL., ALIMENT PHARMACOL THER, vol. 15, 2001, pages 429 - 438
   CLIBON ET AL., EXP HEMATOL, vol. 18, 1990, pages 438 - 441
   JELKMANN ET AL., ANN NY ACAD SCI, vol. 718, 1991, pages 300 - 311
   MACDOUGALL; COOPER, NEPROL DIAL TRANSPLANT, vol. 17, no. 11, 2002, pages 39 - 43
   GENNARO, A.R.: "Remington's Pharmaceutical Sciences, 18th ed.,", 1990, MACK PUBLISHING CO.
   HARDMAN, J.G., LIMBIRD, L.E., AND GILMAN, A.G.,: "The Pharmacological Basis of Therapeutics, 10th ed.", 2001, MCGRAW-HILL CO.
   COLOWICK, S. ET AL.,: "Methods In Enzymology", ACADEMIC PRESS, INC.
   WEIR, D.M., AND BLACKWELL, C.C.,: "Handbook of Experimental Immunology", vol. I-IV, 1986, BLACKWELL SCIENTIFIC PUBLICATIONS
   MANIATIS, T. ET AL.,: "Molecular Cloning: A Laboratory Manual 2nd edition,", vol. I-III, 1989, COLD SPRING HARBOR LABORATORY PRESS
   AUSUBEL, P.M. ET AL.,: "Short Protocols in Molecular Biology, 4th edition,", 1999, JOHN WILEY & SONS
   REAM ET AL.,: "Molecular Biology Techniques: An Intensive Laboratory Course", 1998, ACADEMIC PRESS
   NEWTON, C.R., AND GRAHAM, A.,: "PCR (Introduction to Biotechniques Series, 2nd ed.,", January 1999, SPRINGER VERLAG
   LIN ET AL., PROC NATL ACAD SCI USA, vol. 82, 1985, pages 7580 - 7584
   JIANG ET AL., J BIOL CHEM, vol. 272, 1997, pages 19253 - 19260
   SRINIVAS ET AL., BIOCHEM BIOPHYS RES COMMUN, vol. 260, 1999, pages 557 - 561
   IVAN; KAELIN, SCIENCE, vol. 292, 2001, pages 464 - 468
   TAYLOR, GENE, vol. 275, 2001, pages 125 - 132
   ARAVIND; KOONIN, GENOME BIOL, vol. 2, 2001
   EPSTEIN ET AL., CELL, vol. 107, 2001, pages 43 - 54
   BRUICK; MCKNIGHT, SCIENCE, vol. 294, 2001, pages 1337 - 1340
   DUPUY ET AL., GENOMICS, vol. 69, 2000, pages 348 - 54
   MAJAMAA ET AL., EUR J BIOCHEM, vol. 138, 1984, pages 239 - 245
   MAJAMAA ET AL., BIOCHEM J, vol. 229, 1985, pages 127 - 133
   KIVIRIKKO; MYLLYHARIU, MATRIX BIOL, vol. 16, 1998, pages 357 - 368
   BICKEL ET AL., HEPATOLOGY, vol. 28, 1998, pages 404 - 411
   FRIEDMAN ET AL., PROC NATL ACAD SCI USA, vol. 97, 2000, pages 4736 - 4741
   FRANKLIN, BIOCHEM SOC TRANS, vol. 19, 1991, pages 812 - 815
   FRANKLIN ET AL., BIOCHEM J, vol. 353, 2001, pages 333 - 338
   MEANS, STEM CELLS, vol. 13, 1995, pages 32 - 37
   SALVARANI ET AL., RHEUMATOL INT, vol. 16, 1996, pages 45 - 48
   GOCH ET AL., EUR J HEMATOL, vol. 55, 1995, pages 73 - 77
   CLIBON ET AL., EXP HEMATOL, vol. 18, 1990, pages 43 8 - 441
   BOTTOMLEY; MULLER-EBERHARD, SEMIN HEMATOL, vol. 25, 1988, pages 282 - 302
   YIN ET AL., BLOOD, CELLS, MOLECULES, AND DISEASES, vol. 24, no. 3, 1998, pages 41 - 533
   GOSWAMI ET AL., BIOCHEM CELL BIOL, vol. 80, 2002, pages 679 - 689
   HANSON ET AL., J BIOL CHEM, vol. 274, 1999, pages 5047 - 5052
   KLAUSNER ET AL., CELL, vol. 72, 1993, pages 19 - 28
   HAILE, AM J MED SCI, vol. 318, 1999, pages 230 - 240
   GUNSHIN ET AL., FEBS LETT, vol. 509, 2001, pages 309 - 316
   CANONNE-HERGAUX ET AL., BLOOD, vol. 93, 1999, pages 4406 - 4417
   MCKIE ET AL., SCIENCE, vol. 291, 2001, pages 1755 - 1759
   TRAN ET AL., J NUTR, vol. 132, 2002, pages 351 - 356
   EPSTEIN, CELL, vol. 107, 2001, pages 43 - 54
   MYLLYHARJU; KIVIRIKKO, EMBO J, vol. 16, 1997, pages 1173 - 1180
   THORNBURG ET AL., EMBO J, vol. 32, 1993, pages 14023 - 14033
   JIA ET AL., PROC NATL ACAD SCI USA, vol. 91, 1994, pages 7227 - 7231
   KIVIRIKKO; MYLLYHARJU, MATRIX BIOL, vol. 16, 1998, pages 357 - 368
   MAJAMAA ET AL., BIOCHEM J, vol. 229, pages 127 - 133
   PALMERINI ET AL., J CHROMATOGR, vol. 339, 1985, pages 285 - 292
   CUNLIFFE ET AL., BIOCHEM J, vol. 240, 1986, pages 617 - 619
   KAULE; GUNZLER, ANAL BIOCHEM, vol. 184, 1990, pages 291 - 297
   IVAN ET AL., SCIENCE, vol. 292, 2001, pages 464 - 468
   PROC NATL ACAD SCI USA, vol. 99, 2002, pages 13459 - 13464
   HIRSILA ET AL., J BIOL CHEM, vol. 278, 2003, pages 30772 - 30780
   CENTER FOR DRUG EVALUATION AND RESEARCH (U.S.) DIVISION OF DRUG INFORMATION RESOURCES: "Inactive Ingredient Guide", 1996, CENTER FOR DRUG INFORMATION RESOURCES
   ASH: "Handbook of Pharmaceutical Additives", 2002, SYNAPSE INFORMATION RESOURCES, INC.
   BEVILACQUA ET AL., PROC NATL ACAD SCI USA, vol. 84, 1987, pages 9238 - 9242
   BEVILACQUA; VAN FURTH, J LEUKOC BIOL, vol. 54, 1993, pages 363 - 378
   SARTOR ET AL., INFECTION AND IMMUNITY, vol. 57, 1989, pages 1177 - 1185
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.